Envista Holdings, the dental spin-off of Danaher, raised almost $590 million from an initial public offering completed September 18.
The company sold nearly 27 million shares at $22 a share on the first day it was available. Shares closed at just under $28 per share, up 27%.
Envista is the parent company of KaVo Kerr, Nobel Biocare, and Ormco.
